Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calorie intake is a physiological process reflecting the total amount of energy consumed through food and beverages, which is fundamental to maintaining metabolic balance and cellular function [4, 10]. It is not a discrete molecular target or receptor but is regulated by a complex interplay of peripheral hormonal signals and central nervous system circuits, primarily located in the hypothalamus [5, 13]. Hormones such as leptin, ghrelin, and glucagon-like peptide-1 (GLP-1) provide feedback to the brain regarding energy stores and immediate satiety, which in turn influences eating behavior [13]. Dysregulation of calorie intake, particularly chronic overconsumption, is a key driver of obesity, type 2 diabetes, and metabolic syndrome, while caloric restriction has been shown to modulate aging pathways like AMPK and mTOR [3, 9, 15]. Pharmacological interventions aimed at managing body weight often focus on reducing calorie intake by targeting specific receptors, such as the GLP-1 receptor or melanocortin 4 receptor (MC4R) [13, 14]. These drugs, including agonists like semaglutide and setmelanotide, effectively mimic or enhance natural satiety signals to reduce food consumption and treat metabolic diseases [11, 14]. Thus, while calorie intake itself is a behavioral and physiological outcome, its management is central to the therapeutic strategy for a range of metabolic and age-related conditions [8, 11].
Reduction of calorie intake is achieved through several mechanisms including GLP-1 receptor agonism to enhance satiety [11, 13], melanocortin 4 receptor (MC4R) activation to suppress appetite [13, 14], inhibition of gastric and pancreatic lipases to reduce fat absorption [14], and modulation of central reward and hunger circuits [13].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calorie intake.